Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Korean Court Upholds Employee Non-competition Clause In LG Contract; Puts Brakes On Samsung's Manhunt For Biosimilar Specialists

This article was originally published in PharmAsia News

Executive Summary

SEOUL - A Seoul district court has derailed, for the time being, Samsung Electronics' efforts to snatch up biosimilars experts from competitors including LG Life Sciences
Advertisement

Related Content

Hanwha Files For Korea Approval For Biosimilar Of Amgen’s Enbrel
Samsung Electronics Takes Step Into Korea's Biosimilar Foray With IND For MabThera Generic
Samsung Electronics Takes Step Into Korea's Biosimilar Foray With IND For MabThera Generic
Celltrion To Cancel 3.99 Percent Of Its Shares To Add Value For Shareholders
Celltrion To Cancel 3.99 Percent Of Its Shares To Add Value For Shareholders
Samsung Group Set To Enter Biosimilars Market With $1.9 Billion Investment
Korea's Samsung Electronics On Manhunt For Biosimilar Talent As Local Companies Keep Wary Eye On Competition
Korea's Samsung Electronics On Manhunt For Biosimilar Talent As Local Companies Keep Wary Eye On Competition
Korean Government Announces Joint Fund To Beef Up Local Pharma Industry
Korea Moves To Help Samsung Electronics Create Consortium in Biosimilars
Advertisement
UsernamePublicRestriction

Register

SC075285

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel